Vitalife closes first fund
The addition of HarbourVest Partner to Israeli life sciences venture capital fund Vitalife prompted the fund to announce on Monday the closing of its first fund, worth €46 million.
The addition of HarbourVest Partner to Israeli life sciences venture capital fund Vitalife prompted the fund to announce on Monday the closing of its first fund, worth €46 million.
Researchers have now completed the sequencing of the human genome, to an accuracy of 99.999 per cent, nearly three years after the first 'working' draft was published to great fanfare in June 2000. The achievement comes 50 years after James Watson and...
UK biotechnology bellwether Celltech has emerged victorious in the bidding battle for Oxford GlycoSciences. OGS reluctantly gave in to Celltech's pressure on 11 April, after the latter firm bought additional holdings which brought its stake in OGS to...
German packaging company Bosch Packaging Technology will reveal a host of products at the upcoming exhibition on chemical engineering and biotechnology to be held in Frankfurt, Germany in May this year. Brand new on the stand, filling and sealing...